Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy.
Zhang W
,
Watson CE
,
Liu C
,
Williams KJ
,
Werth VP
.
???displayArticle.abstract???
Glucocorticoid (GC) administration induces atrophy of skin, bone, and other organs, partly by reducing tissue content of glycosaminoglycans, particularly hyaluronic acid (HA). We took advantage of the recent cloning of the three human hyaluronan synthase (HAS) enzymes (HAS1, HAS2 and HAS3), to explore the molecular mechanisms of this side effect. Northern and slot blots performed on RNA extracted from cultured dermal fibroblasts and the MG-63 osteoblast-like osteosarcoma cell line indicated that HAS2 is the predominant HAS mRNA in these cells. Incubation of both cell types for 24 h in the presence of 10(-6) M dexamethasone (DEX) resulted in a striking 97--98% suppression of HAS2 mRNA levels. Time-course studies in fibroblasts demonstrated suppression of HAS2 mRNA to 28% of control by 1 h, and to 1.2% of control by 2 h, after addition of DEX. Dose-response studies in fibroblasts indicated that the majority of the suppressive effect required concentrations characteristic of cell-surface GC receptors, a point confirmed by persistent DEX-induced suppression in the presence of RU486, an antagonist of classic cytosolic steroid hormone receptors. Nuclear run-off experiments showed a 70% suppression of HAS2 gene transcription in nuclei from DEX-treated fibroblasts, which is unlikely to fully explain the rapid 50--80-fold reduction in message levels. Experiments with actinomycin D (AMD) demonstrated that the message half-life was 25 min in cells without DEX, whereas the combination of AMD with DEX dramatically increased the half-life of HAS2 mRNA, suggesting that DEX acts by inducing a short-lived destabilizer of the HAS2 message. Direct assessment of HAS2 mRNA stability by wash-out of incorporated uridine label established a half-life of 31 min in cells without DEX, which substantially shortened in the presence of DEX. In conclusion, GCs induce a rapid and sustained, near-total suppression of HAS2 message levels, mediated through substantial decreases in both gene transcription and message stability. These effects may contribute to the loss of HA in GC-treated organs.
Agren,
Hydrocortisone regulation of hyaluronan metabolism in human skin organ culture.
1995, Pubmed
Agren,
Hydrocortisone regulation of hyaluronan metabolism in human skin organ culture.
1995,
Pubmed
Akeson,
Effects of immobilization on joints.
1987,
Pubmed
Autio,
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect.
1994,
Pubmed
Bode-Lesniewska,
Distribution of the large aggregating proteoglycan versican in adult human tissues.
1996,
Pubmed
Brecht,
Increased hyaluronate synthesis is required for fibroblast detachment and mitosis.
1986,
Pubmed
,
Xenbase
Brown,
Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit.
1991,
Pubmed
Burnstein,
Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation.
1990,
Pubmed
Buttgereit,
A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited.
1998,
Pubmed
Capewell,
Purpura and dermal thinning associated with high dose inhaled corticosteroids.
1990,
Pubmed
Cato,
Molecular mechanisms of anti-inflammatory action of glucocorticoids.
1996,
Pubmed
Ellis,
Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing.
1996,
Pubmed
Feinberg,
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.
1984,
Pubmed
Fraser,
Hyaluronan: its nature, distribution, functions and turnover.
1997,
Pubmed
Freund,
Serial quantitation of hyaluronan and sulfated glycosaminoglycans in fetal sheep skin.
1993,
Pubmed
Fülöp,
Coding sequence of a hyaluronan synthase homologue expressed during expansion of the mouse cumulus-oocyte complex.
1997,
Pubmed
,
Xenbase
Genever,
Influence of vitamin D status on hyaluronan localization in bone.
1996,
Pubmed
Itano,
Molecular cloning of human hyaluronan synthase.
1996,
Pubmed
,
Xenbase
Kato,
Stimulation by glucocorticoid of the synthesis of cartilage-matrix proteoglycans produced by rabbit costal chondrocytes in vitro.
1985,
Pubmed
Kongtawelert,
Pentosan polysulfate (Cartrophen) prevents the hydrocortisone induced loss of hyaluronic acid and proteoglycans from cartilage of rabbit joints as well as normalizes the keratan sulfate levels in their serum.
1989,
Pubmed
Kosaki,
Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
1999,
Pubmed
Laurent,
Hyaluronan.
1992,
Pubmed
Lavker,
Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
1992,
Pubmed
LeBaron,
Hyaluronate binding properties of versican.
1992,
Pubmed
McCrohon,
Estrogen and progesterone reduce lipid accumulation in human monocyte-derived macrophages: a sex-specific effect.
1999,
Pubmed
McDevitt,
Interaction of intact type VI collagen with hyaluronan.
1991,
Pubmed
Meisler,
Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts.
1997,
Pubmed
Melhus,
Cloning of a novel retinoic acid-inducible mRNA from human osteoblast-like cells.
1997,
Pubmed
Meyer,
Age-dependent changes of hyaluronan in human skin.
1994,
Pubmed
Mian,
Analysis of cell-growth-phase-related variations in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts.
1986,
Pubmed
,
Xenbase
Myers,
Suppression of hyaluronic acid synthesis in synovial organ cultures by corticosteroid suspensions.
1985,
Pubmed
Reid,
Glucocorticoid osteoporosis--mechanisms and management.
1997,
Pubmed
Robey,
Structure and molecular regulation of bone matrix proteins.
1993,
Pubmed
Smith,
Glucocorticoid regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts: evidence for a receptor-mediated mechanism involving effects on specific de novo protein synthesis.
1988,
Pubmed
Spicer,
Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase.
1997,
Pubmed
,
Xenbase
Spicer,
Chromosomal localization of the human and mouse hyaluronan synthase genes.
1997,
Pubmed
,
Xenbase
Spicer,
Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family.
1998,
Pubmed
,
Xenbase
Sugiyama,
Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells.
1998,
Pubmed
,
Xenbase
Suzuki,
Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C.
1995,
Pubmed
Tammi,
Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces.
1994,
Pubmed
Tiedemann,
Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects.
1997,
Pubmed
Tomkins,
Control of specific gene expression in higher organisms. Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA.
1969,
Pubmed
Tukey,
Quantitation of related gene products by nuclear run-on and northern blot analysis.
1991,
Pubmed
Uzuka,
The mechanism of estrogen-induced increase in hyaluronic acid biosynthesis, with special reference to estrogen receptor in the mouse skin.
1980,
Pubmed
Watanabe,
Molecular identification of a putative human hyaluronan synthase.
1996,
Pubmed
,
Xenbase
Weigel,
Hyaluronan synthases.
1997,
Pubmed
,
Xenbase
Werth,
UVB irradiation alters cellular responses to cytokines: role in extracellular matrix gene expression.
1997,
Pubmed
Werth,
Lack of correlation of skin thickness with bone density in patients receiving chronic glucocorticoid.
1998,
Pubmed
Yamada,
The gene structure and promoter sequence of mouse hyaluronan synthase 1.
1998,
Pubmed
,
Xenbase
Yoshikawa,
Effect of glucocorticoid on glycosaminoglycans synthesis in cultured mouse embryonic palatal mesenchymal cells.
1986,
Pubmed
Zhu,
Phorbol esters selectively downregulate contractile protein gene expression in terminally differentiated myotubes through transcriptional repression and message destabilization.
1991,
Pubmed